Exercise Intensity for Cardiorespiratory Fitness
(REVISE Trial)
Trial Summary
What is the purpose of this trial?
In this proposal, the investigators challenge the assumption that following the physical activity guidelines implies benefit for ALL adults, and that if benefit is not achieved in response to first line therapy, it will be by simply exercising more. Thus, for improving cardiorespiratory fitness and cardiometabolic risk factors, unanswered questions include: 1) To what extent, regardless of increasing exercise intensity or amount, is exercise not associated with benefit? Demonstration of a resistance to benefit through exercise in a substantial number of adults would be a novel and important finding, would counter the assumptions of many if not most health care practitioners, and could have immediate and direct application in all health care settings. 2) To what extent will non-responders to first line therapy (150 min/wk) be required to increase exercise intensity or amount to achieve benefit? 3) To what extent will failure to improve CRF segregate (be associate with) with cardiometabolic risk factors? The investigators propose that adults who remain exercise resistant for improvement in CRF and cardiometabolic risk despite increasing amount or intensity are at high risk of metabolic disease and consequently, are candidates for alternative treatment strategies.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications.
What data supports the effectiveness of the treatment Exercise Intensity for Cardiorespiratory Fitness?
Research shows that high-intensity interval training (HIIT) can significantly improve peak oxygen uptake, which is a measure of cardiorespiratory fitness, in various patient groups, including heart transplant recipients and those with coronary artery disease. This suggests that similar high-intensity exercise treatments could be effective in improving fitness levels.12345
Is high-intensity interval training (HIIT) safe for people with cardiovascular and metabolic diseases?
Research shows that high-intensity interval training (HIIT) is generally safe for people with cardiovascular and metabolic diseases, with a low rate of major adverse events. However, caution is advised, and it is important for individuals to be clinically stable, have prior experience with moderate exercise, and be supervised during sessions.678910
How does the exercise intensity treatment for cardiorespiratory fitness differ from other treatments?
This treatment is unique because it involves varying levels of exercise intensity and volume, such as high-intensity interval training (HIIT) and low-volume high-intensity exercise, which can potentially improve cardiorespiratory fitness more effectively than moderate-intensity continuous training. Unlike other treatments, it focuses on short bursts of intense activity interspersed with rest, which may lead to different metabolic adaptations and improvements in fitness.1112131415
Research Team
Robert Ross, PhD
Principal Investigator
Queen's University
Eligibility Criteria
This trial is for adults who lead a sedentary lifestyle, exercising no more than once a week, have had a stable weight for the past 6 months, and have a BMI between 20-40. It's not suitable for individuals with diabetes, current smokers, those planning to move soon or anyone with physical impairments that make exercise difficult or unsafe.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
First Line Therapy
Participants engage in 150 minutes per week of moderate physical activity (MPA) for 16 weeks to assess initial response in cardiorespiratory fitness (CRF) and cardiometabolic risk factors.
Increased Exercise Intensity/Amount
Participants who do not respond to first line therapy increase exercise intensity or amount for an additional 16 weeks to evaluate changes in CRF and cardiometabolic risk factors.
Follow-up
Participants are monitored for safety and effectiveness after the exercise intervention phases.
Treatment Details
Interventions
- High amount, high intensity exercise
- Low amount, high intensity exercise
- Low amount, low intensity exercise
Find a Clinic Near You
Who Is Running the Clinical Trial?
Robert Ross, PhD
Lead Sponsor
Robert Ross, PhD
Lead Sponsor
Queen's University
Lead Sponsor